Virucidal treatment of clotting factor concentrates.
D004340:Drug Contamination / Q000517:prevention & control*; D005069:Evaluation Studies as Topic; D005164:Factor IX / Q000009:adverse effects / Q000627:therapeutic use*; D005169:Factor VIII / Q000009:adverse effects / Q000627:therapeutic use*; D005612:Freeze Drying; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy; D006505:Hepatitis / Q000201:enzymology / Q000517:prevention & control*; D006509:Hepatitis B / Q000201:enzymology / Q000517:prevention & control; D006526:Hepatitis C / Q000201:enzymology / Q000517:prevention & control; D006358:Hot Temperature; D006801:Humans; D011358:Product Surveillance, Postmarketing; D012307:Risk Factors; D000637:Transaminases / Q000097:blood; D014775:Virus Activation
D005169:Factor VIII; D005164:Factor IX; D000637:Transaminases